about
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastomaGoing straight to the source: A pilot study of bereaved parent-facilitated communication training for pediatric subspecialty fellows.A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastomaPhase I study of sunitinib and irinotecan for patients with recurrent malignant glioma.Bevacizumab and daily temozolomide for recurrent glioblastoma.Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.Correlates of quality of life-related outcomes in breast cancer patients participating in the Pathfinders pilot study.Informational needs assessment of non-Hodgkin lymphoma survivors and their physiciansPatient-controlled analgesia at the end of life at a pediatric oncology institutionTetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patientsPatterns of End-of-Life Care in Children With Advanced Solid Tumor Malignancies Enrolled on a Palliative Care ServicePrognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancerFeasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma.Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.Play-based procedural preparation and support intervention for cranial radiation.Adolescents' preferences for treatment decisional involvement during their cancer.Measurable Supratentorial White Matter Volume Changes in Patients with Diffuse Intrinsic Pontine Glioma Treated with an Anti-Vascular Endothelial Growth Factor Agent, Steroids, and Radiation.Palliative Care Involvement Is Associated with Less Intensive End-of-Life Care in Adolescent and Young Adult Oncology Patients.Evaluation of a fever-management algorithm in a pediatric cancer center in a low-resource setting.Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells.The bereavement experience of adolescents and early young adults with cancer: Peer and parental loss due to death is associated with increased risk of adverse psychological outcomes.Nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) in pediatric and young adult patients: Results from a prospective study using limited-margin radiotherapy.Children with minimal chance for cure: parent proxy of the child's health-related quality of life and the effect on parental physical and mental health during treatment.Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life.Prevalence, risk factors, and response to treatment for hypersomnia of central origin in survivors of childhood brain tumors.Patients' and Parents' Needs, Attitudes, and Perceptions About Early Palliative Care Integration in Pediatric Oncology.Illness and end-of-life experiences of children with cancer who receive palliative care.Comparison of Resting Energy Expenditure Assessment in Pediatric Oncology Patients.The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia.Ethical decision making about end-of-life care issues by pediatric oncologists in economically diverse settings.Poor drug distribution as a possible explanation for the results of the PRECISE trial.Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer.Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia [Formula: see text].Predictors of Late Palliative Care Referral in Children with Cancer.Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.Incorporating Bereaved Parents as Faculty Facilitators and Educators in Teaching Principles of Palliative and End-of-Life CarePredictors of Location of Death for Children with Cancer Enrolled on a Palliative Care ServiceRapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapyClinical Characteristics of Children and Adolescents Undergoing Hematopoietic Cell Transplantation Who Develop Oral MucositisReducing Compassion Fatigue in Inpatient Pediatric Oncology Nurses
P50
Q28731711-8FE055FF-F631-483F-B02B-A0250BE32B2FQ30151800-1B14D66C-DB73-413E-9615-803BAA1E4E67Q30408669-F0C66F40-5557-4A11-8BE0-64BDC44FD879Q33396181-3280DB22-4A64-4929-BCDC-9D1BFB83C707Q33396384-6D5CE8EE-8B74-4F23-AA36-24AB7A4EEC6BQ33399939-99E167B8-561D-4202-9F59-E52C2EACC1BBQ34453788-82256CD7-D30D-4FBA-8C3E-E912803ED20BQ35178741-8C8FCA92-D1D7-4546-8D58-19A37CF64063Q35612297-A1B8C7DB-0104-4E81-8966-732A9FED35D0Q35878158-9DF20390-BA66-4691-BE5A-E8FC7402D1F4Q35998312-8982E89E-744F-470C-BB1A-02E6780B4815Q36737540-7E8A6A2C-2F04-42BA-A69E-1927124ADB59Q36927476-84569A27-8499-4CB8-A378-7D46A4C4AAC9Q37113191-EDE6D59E-1692-4782-B725-8D1066EF3116Q37316800-A2EB07FE-935C-46A0-86D5-B680FF4A2C10Q38404299-EA988A54-7610-4D13-A127-30EA981E8811Q38827788-FAC1B9DD-D56C-4748-9D56-2FA9C9B40093Q39014941-98BDC3BF-8C3F-4469-BB1E-A90180E2631DQ40039417-7910DF0F-4727-4939-BC39-B57BAB11BCD2Q40577658-6CAD1EB8-BE22-4B1C-9482-9A4B1C61B5C1Q41498671-7772FDEB-B525-4293-A484-EB3FDDC2CD24Q46057029-A97F8C40-3F5E-4985-8B1C-AF7218D14EC0Q47140927-22BCD452-14C9-4E1C-A0A5-14776BA772A4Q47183987-665FF850-A9B5-47E2-A00D-BE519A99D6E3Q47223312-49BC1CD8-6E1A-4792-9F0B-8A78C0808F98Q47336499-5944C16C-1B7F-4052-9532-2B70987BF09BQ47346087-DBFCA6D6-5765-4083-B601-02E3BCCC7E2DQ47552702-6A638E0D-FC15-42BD-A876-5D4471238DA4Q47700569-0BA4E09E-680A-45F6-8B3D-672B1E5A5BCCQ48040674-6CB94D32-4FC4-4EC4-B604-A4A5741F1616Q48374857-F7970AC3-7B9E-4563-BFA1-F86142B2283BQ48420234-DE3091FC-5AA8-4F32-A9FE-CB80E1CC524DQ49838778-DD5DA90D-3DE9-46DB-83C3-FD5926A0F00AQ50086385-D4CB70BD-D391-4D09-B88C-126AF994FD75Q55384079-6B279ED0-0502-4BB2-AB1E-D2494C854890Q62023542-5E21D3B6-25FC-418E-B70A-B7E108AADCD8Q62023543-54F6CB6F-C68E-4102-94E8-B35286F2CC7FQ62023544-3D99A8E1-453F-41F7-9E31-22CBEAA3EF13Q89276540-128E9875-3FA4-41FF-B24A-791F90B7C0AFQ90100394-1FC7EF06-CC05-42C6-B325-42736A143C32
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
April Coan
@ast
April Coan
@en
April Coan
@es
April Coan
@nl
type
label
April Coan
@ast
April Coan
@en
April Coan
@es
April Coan
@nl
altLabel
April Coan
@en
April D Coan
@en
prefLabel
April Coan
@ast
April Coan
@en
April Coan
@es
April Coan
@nl
P1053
N-4407-2018
P106
P21
P31
P3829
P496
0000-0002-7667-8155